(Generic version of Ozempic® / Wegovy®)

• Class: GLP-1 Receptor Agonist

• How it works: Mimics GLP-1 to reduce appetite, slow digestion, and improve insulin response.

• Typical dosing:

  • Starting dose: 0.25 mg weekly

  • Maintenance dose: 1.0–2.4 mg weekly (Wegovy is typically titrated to 2.4 mg)

• FDA-approved for: Type 2 diabetes (Ozempic), obesity, and weight loss (Wegovy)

• Other benefits: Cardiovascular protection, reduced risk of diabetes progression

• Administration: Once-weekly injection provided in our office.

💡Ideal for patients who live near Burbank, CA that prefer not to self-administer the medication.